BTA 0.00% 57.0¢ biota holdings limited

Ann: Phase III prophylaxis trial for CS-8958 , page-23

  1. 2,630 Posts.
    lightbulb Created with Sketch. 4
    Jessie, Interesting document.

    Inclusion Criteria = "Subjects judged as negative for influenza virus infection using a specified diagnostic kit"

    Candidates in trial were pre-exposed to infection - but before development of symptoms (blood temp checked) or judged as negative to infection with above kit. I presume kit meassures antibodies to influenza.

    What if the diagnostic kit is fallible? ie - candidate has had sufficient exposure for influenza development but cannot be detected at outset of trial?

    If 50% of candidates in this category and other 50% were prevented then we have an exceptionally good result.

    Is this possible??
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.